PRELP negatively regulates IL-17A-mediated proliferation and the inflammatory response in psoriasis
{{output}}
Psoriasis is a common immune-mediated skin disease driven largely by interleukin-17A (IL-17A). Although IL-17A plays a key role in disease pathogenesis, the underlying mechanisms remain incompletely understood. Through bioinformatic analysis, we discovered tha... ...
